Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: A real-life worldwide observational study (EDGE)
C. Mathieu, A. H. Barnett, H. Brath, I. Conget, J. J. de Castro, R. Goeke, E. Marquez Rodriguez, Marie P Nilsson, E. Pagkalos, A. Penfornis, N. C. Schaper, S. K. Wangnoo, W. Kothny, G. Bader
Research output: Contribution to journal › Article › peer-review